Stroke · older adults with primary hypertension
Higher BP target (< 150‐160/95‐105 mmHg) showed no clear difference in stroke compared with lower BP target (< 140/90 mmHg) (low certainty).
1 finding from 1 review
Serious adverse events: cardiovascular events · older adults with primary hypertension
Higher BP target (< 150‐160/95‐105 mmHg) showed no clear difference in cardiovascular serious adverse events compared with lower BP target (< 140/90 mmHg) (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · older adults with primary hypertension
Higher BP target (< 150‐160/95‐105 mmHg) showed no clear difference in withdrawals due to adverse effects compared with lower BP target (< 140/90 mmHg) (low certainty).
1 finding from 1 review
Pain‐free at 2 hours · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pain‐free at different time points (1, 4, 24 hours) · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pain‐free or mild pain at 2 hours · adults with episodic tension‐type headache
1 finding from 1 review
Use of rescue medication · adults with episodic tension‐type headache
1 finding from 1 review
Patient Global Evaluation at end of study · adults with episodic tension‐type headache
1 finding from 1 review
Any adverse event · adults with episodic tension‐type headache
1 finding from 1 review
Specific adverse events · adults with episodic tension‐type headache
1 finding from 1 review
Serious adverse events · adults with episodic tension‐type headache
1 finding from 1 review
Total mortalitya · hypotensive shock
Dopamine showed no clear difference in total mortalitya compared with norepinephrine (high certainty).
1 finding from 1 review
Arrhythmias · hypotensive shock
Dopamine leads to higher arrhythmia < BR/> compared with norepinephrine (high certainty).
1 finding from 1 review
Total mortalitya · hypotensive shock
It is very uncertain whether terlipressin changes total mortalitya compared with norepinephrine (very low certainty).
1 finding from 1 review
Total mortalitya · hypotensive shock
Vasopressin showed no clear difference in total mortalitya compared with norepinephrine (moderate certainty).
1 finding from 1 review
Total mortalitya · hypotensive shock
It is very uncertain whether phenylephrine changes total mortalitya compared with norepinephrine (very low certainty).
1 finding from 1 review
Total mortalitya · hypotensive shock
Epinephrine showed no clear difference in total mortalitya compared with norepinephrine (low certainty).
1 finding from 1 review
Intervention not reported
End of treatment SBP (over 12 weeks) · patients with primary hypertension
1 finding from 1 review
Intervention not reported
End of treatment DBP (over 12 weeks) · patients with primary hypertension
1 finding from 1 review
Intervention not reported
Withdrawals due to adverse effects · patients with primary hypertension
1 finding from 1 review